Bristol-Myers, Others Appeal Revlimid MDL To 3rd Circ.
Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the...To view the full article, register now.
Already a subscriber? Click here to view full article